Nemes Rush Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79K | Hold |
700
| – | – | ﹤0.01% | 473 |
|
|
2025
Q1 | $9.52K | Hold |
700
| – | – | ﹤0.01% | 465 |
|
|
2024
Q4 | $14.3K | Hold |
700
| – | – | ﹤0.01% | 431 |
|
|
2024
Q3 | $14.4K | Hold |
700
| – | – | ﹤0.01% | 369 |
|
|
2024
Q2 | $16.3K | Hold |
700
| – | – | ﹤0.01% | 362 |
|
|
2024
Q1 | $14.4K | Hold |
700
| – | – | ﹤0.01% | 406 |
|
|
2023
Q4 | $15K | Hold |
700
| – | – | ﹤0.01% | 384 |
|
|
2023
Q3 | $14.4K | Hold |
700
| – | – | ﹤0.01% | 367 |
|
|
2023
Q2 | $20.7K | Buy |
+700
| New | +$20.7K | ﹤0.01% | 363 |
|